Laura Farmer brings a wealth of experience as a seasoned life sciences consultant, having thrived in strategic advisory, competitive intelligence and digital health roles catering to top-tier pharmaceutical, medical device, and diagnostic companies. Her expertise spans diverse therapeutic areas including oncology, immunology, CV/met, CNS/psych, urology, rare diseases and more. Laura possesses a distinctive knack for identifying emerging health trends and disruptive competitor developments, which translates into effectively guiding clients in commercialization strategies, resource allocation, potential acquisitions and landscape analyses.
Laura is skilled in conducting primary research and engaging in insightful stakeholder interviews with healthcare professionals, payers, and patients to uncover unmet needs, and characterize market dynamics. She is also adept at orchestrating cross-functional workshops involving R&D, brand, regulatory, and market access teams to validate assumptions and craft strategic solutions. Laura’s capabilities extend to shaping go-to-market strategies, prioritizing customer targeting, pressure-testing value proposition messaging and identifying reimbursement dynamics for medical devices and drugs. She has a successful track record in evaluating global markets for emerging technologies, such as diagnostic devices, genetic screening tests, RNA platforms, and digital tools for clinical trials, consistently identifying valuable partnership and investment opportunities for her clients.
Laura facilitated product launches and spearheaded competitive intelligence efforts during her tenure as EVP of Larvol, a competitive intelligence & SAAS product life sciences company. She also served as SVP of business development at Real Endpoints, a boutique market access consultancy, helping clients gain competitive advantage based on insights from close payer relationships. Over the course of her career, Laura has led a wide range of strategy projects with Business Talent Group (BTG), Putnam Associates, Insight Strategy Advisors, Straticore, CSC Healthcare, and The Wilkerson Group (IBM Consulting) for top pharmaceutical and biotech firms. Laura has a B.A. cum laude in pre-medical studies and political science with distinction from Yale University. She is a professional opera singer and finds time to perform in several productions each year.